Literature DB >> 8837461

Iron withholding: a defense against viral infections.

E D Weinberg1.   

Abstract

A variety of laboratory and clinical investigations during the past 15 years have observed that one of the dangers of excessive iron is its ability to favor animal viral infections. The metal is essential for host cell synthesis of virions and can also impair defense cell function and increase oxidative stress. In both animal models and humans, viral infections cause upregulation of the iron withholding defense system. Factors that suppress the system enhance viral progression; factors that strengthen the system augment host defense. Procedures designed to reinforce the system are being developed and tested; some of these may become useful adjuncts in prevention and management of viral diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8837461     DOI: 10.1007/bf00140609

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  39 in total

Review 1.  Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management.

Authors:  J R Boelaert; G A Weinberg; E D Weinberg
Journal:  Infect Agents Dis       Date:  1996-01

2.  Serum iron levels and response to hepatitis B virus.

Authors:  C Felton; E D Lustbader; C Merten; B S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

3.  Inhibition of human immunodeficiency virus infectivity by chloroquine.

Authors:  W P Tsai; P L Nara; H F Kung; S Oroszlan
Journal:  AIDS Res Hum Retroviruses       Date:  1990-04       Impact factor: 2.205

4.  Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.

Authors:  S Fargion; A Piperno; M D Cappellini; M Sampietro; A L Fracanzani; R Romano; R Caldarelli; R Marcelli; L Vecchi; G Fiorelli
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

5.  Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis.

Authors:  S L Newman; L Gootee; G Brunner; G S Deepe
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase.

Authors:  G Karupiah; Q W Xie; R M Buller; C Nathan; C Duarte; J D MacMicking
Journal:  Science       Date:  1993-09-10       Impact factor: 47.728

Review 7.  Hepatocellular carcinoma and African iron overload.

Authors:  I T Gangaidzo; V R Gordeuk
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

8.  Response to interferon alpha therapy is influenced by the iron content of the liver.

Authors:  D H Van Thiel; L Friedlander; S Fagiuoli; H I Wright; W Irish; J S Gavaler
Journal:  J Hepatol       Date:  1994-03       Impact factor: 25.083

9.  Changes in serum iron levels due to infection with hepatitis B virus.

Authors:  B S Blumberg; E D Lustbader; P L Whitford
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites.

Authors:  G Karupiah; N Harris
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Crossing the Iron Gate: Why and How Transferrin Receptors Mediate Viral Entry.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2018-05-31       Impact factor: 11.848

2.  Evidence for horizontally transferred genes involved in the biosynthesis of vitamin B(1), B(5), and B(7) in Heterodera glycines.

Authors:  James P Craig; Sadia Bekal; Terry Niblack; Leslie Domier; Kris N Lambert
Journal:  J Nematol       Date:  2009-12       Impact factor: 1.402

Review 3.  Particle exposures and infections.

Authors:  A J Ghio
Journal:  Infection       Date:  2014-02-02       Impact factor: 3.553

4.  Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin.

Authors:  Songtao Li; Haibo Zhou; Guirong Huang; Ning Liu
Journal:  Med Microbiol Immunol       Date:  2008-09-23       Impact factor: 3.402

5.  Iron toxicity: new conditions continue to emerge.

Authors:  Eugene D Weinberg
Journal:  Oxid Med Cell Longev       Date:  2009 Apr-Jun       Impact factor: 6.543

Review 6.  Viral Hepatitis and Iron Dysregulation: Molecular Pathways and the Role of Lactoferrin.

Authors:  Romina Mancinelli; Luigi Rosa; Antimo Cutone; Maria Stefania Lepanto; Antonio Franchitto; Paolo Onori; Eugenio Gaudio; Piera Valenti
Journal:  Molecules       Date:  2020-04-24       Impact factor: 4.411

Review 7.  Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation.

Authors:  Elena Campione; Terenzio Cosio; Luigi Rosa; Caterina Lanna; Stefano Di Girolamo; Roberta Gaziano; Piera Valenti; Luca Bianchi
Journal:  Int J Mol Sci       Date:  2020-07-11       Impact factor: 5.923

8.  Iron status predicts malaria risk in Malawian preschool children.

Authors:  Femkje A M Jonker; Job C J Calis; Michael Boele van Hensbroek; Kamija Phiri; Ronald B Geskus; Bernard J Brabin; Tjalling Leenstra
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

Review 9.  Iron metabolism: current facts and future directions.

Authors:  Leida Tandara; Ilza Salamunic
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

Review 10.  Ferroptosis in viral infection: the unexplored possibility.

Authors:  Mao-Peng Wang; Banda Joshua; Ning-Yi Jin; Shou-Wen Du; Chang Li
Journal:  Acta Pharmacol Sin       Date:  2021-12-06       Impact factor: 7.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.